Cardiovascular Diseases

Nuts Linked to Lower Risk of Atrial Fibrillation

A prospective Swedish study suggests that nuts consumption or factors associated with it may play a role in reducing the risk of atrial fibrillation. The study included 61 364 Swedish adults followed up for 17 years. There was an inverse association between nuts consumption and incident atrial fibrillation, and remained after adjustment for multiple risk factors. Compared with no consumption of nuts, the multivariable hazard ratios of atrial fibrillation across categories of nuts consumption were 0.97 for 1–3 times/month, 0.88 for 1–2 times/week and 0.82 for ≥3 times/week. Nuts consumption has been found to be inversely associated with cardiovascular disease mortality as well. Source: http://heart.bmj.com/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.